Browse studies

Find your next paid study

27,295 recruiting studies available now

A Phase 2 De-escalation Study of Dabrafenib and Trametinib for Patients With BRAF V600 Mutant Low-Grade Gliomas

This phase II trial studies how well de-escalating the drugs dabrafenib and trametinib works in treating patients with low-grade gliomas that have a BRAF V600 …

BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT07110246

Phase 2

HRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients With Persistent Hypogonadism After ADT for Treatment of Localized Prostate Cancer

The purpose of this phase II trial is to assess the clinical utility of clomiphene citrate for the augmentation of testosterone in prostate cancer survivors wh…

Prostate Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of NebraskaNCT07882862

Bicuspid Aortic Valve and Ascending Aortic Aneurysm Registry

The purpose of this registry is to gather information on patients with bicuspid aortic valve disease.

Bicuspid Aortic Valve

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT01756222

Observational

OPTImal Ventilation to Improve Pediatric Cardiac Arrest Outcomes (OPTI-VENT)

Pediatric cardiac arrest is a life-threatening problem affecting \>15,000 hospitalized children each year. Less than half of these children survive to hospital…

Cardiac Arrest (CA)

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT07114510

Phase 2

Phase II Randomized Study of Fianlimab Plus Cemiplimab Versus Cemiplimab Plus Placebo in First-Line Treatment of Participants With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Is Positive for PD-L1 Expression

This study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab compared against cemiplima…

Head and Neck Squamous Cell Carcinoma (HNSCC)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT06769698

Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Lupus

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells f…

Lupus

Estimated

~$150 – $3,000

Actual pay is set by the research site.

The Foundation for Orthopaedics and Regenerative MedicineNCT05018858

Observational

Comparing Two Social Needs Assistance Interventions to Improve Health Among Hospitalized Children

The goal of this clinical trial is to determine the best way to help families access social and economic support services in order to improve children's health…

Social NeedsHealth-Related Social NeedsSocial Determinants of Health (SDOH)+3 more

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07687238

Observational

Metabolic Impact of VLCPUFA-Rich Fish Oil: A Clinical Study on Omega-3 Index Enhancement in Healthy Individuals

Background: Fish oils contain omega-3 fatty acids that play important roles in the body. Researchers are studying a new type of fish oil that contains very-lo…

Fatty Acids, Omega-3Fish Oils

Estimated

~$10 – $675

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT07882160

An Observational Study to Assess the Long-term Safety of Ustekinumab Versus Other Biologic Therapies Among Patients With Crohn's Disease and Ulcerative Colitis: A New-User Cohort Study Using the Department of Defense Electronic Health Records Database

The purpose of this study is to estimate and compare the incidence of overall malignancy, serious infection, and opportunistic infections between new users of …

Crohn DiseaseColitis, Ulcerative

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Janssen Scientific Affairs, LLCNCT04372108

Phase 2

A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease

This Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-038 in adults with complement-mediated ki…

IgANC3GComplement-mediated Kidney Disease+2 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

ADARx Pharmaceuticals, Inc.NCT06989359

Phase 3

A Phase 3, Multicenter, Randomized, Open-Label Trial Investigating the Safety, Tolerability and Efficacy of Palopegteriparatide Administered Subcutaneously Daily at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

This trial has a treatment duration of 78 weeks and will include adult participants already on treatment with palopegteriparatide at doses at or greater than 3…

HypoparathyroidismEndocrine System DiseasesParathyroid Diseases

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ascendis Pharma Bone Diseases A/SNCT07081997

Observational

Effectivity of P1821, a Novel Tongue Strengthening and Endurance Enhancing Speech Flow Exercise

The P1821 initiative constitutes an innovative intervention specifically engineered to enhance tongue muscular strength and endurance. The primary objective of…

AnkyloglossiaImpairment of SpeechSlurred Speech

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Dream Video LLCNCT07719582